Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 7 - Drugs for disorders of the blood or the extracellular fluid
Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065)
11/2003
11/06/2003WO2002024891A9 B7-like molecules and uses thereof
11/06/2003WO2001094335A8 Methods for producing chiral chromones, chromanes, amino substituted chromanes and intermediates therefor
11/06/2003WO2001094330A8 Methods for producing amino substituted chromanes
11/06/2003US20030208249 Energy-activated targeted cancer therapy
11/06/2003US20030208067 Inhibitors of protein kinase for the treatment of disease
11/06/2003US20030208058 B7-like polypeptides and polynucleotides
11/06/2003US20030208046 Pseudo native chemical ligation
11/06/2003US20030207920 N-(heterocyclyl)benzene or pyridinesulphonamides as antithrombotic agents and anticoagulants
11/06/2003US20030207919 For treating, preventing, reducing inflammation, pain, fever,gastrointestinal disorders; decreasing gastrointestinal, renal and other toxicities resulting from use of nonsteroidal antiinflammatory drugs; multiplicity of compounds
11/06/2003US20030207918 Administering to patient a bolus injection of an active drug, in particular tirofiban, in an amount of 25 mu g/kg, and administering to the patient, after the bolus injection, an intravenous infusion for a period of 12-72 hours of the drug
11/06/2003US20030207907 Deliverying antirestenoic compound such as an antiproliferative, immunosuppressive, or antiinflammatory drug, particularly rapamycin, tacrolimus, paclitaxel, dexamethasone, or an active analog or derivative thereof
11/06/2003US20030207895 Tissue factor antagonists and methods of use thereof
11/06/2003US20030207893 Antihistamines such as (5-Chloro-1H-indol-2-yl)-(4-methyl-piperazin-1-yl)-methanone, used as antiinflammatory, antiarthritic or bronchodilator agents and/or immunology modulators
11/06/2003US20030207888 Serotonin receptor agonists such as 6-chloro-4-methyl-1,2,3,4 -tetrahydro-2,4a,5-triaza-fluorene, used for prophylaxis of nervous system, cardiovascular, gastrointestinal, eating or sleep disorders, and as antidiabetic agents
11/06/2003US20030207882 Aminoheterocyclic derivatives as antithrombotic or anticoagulant agents
11/06/2003US20030207881 2-adamantylethylamines and their use in the treatment of conditions generally associated with abnormalities in glutamatergic transmission
11/06/2003US20030207870 Aryl ureas with angiogenisis inhibiting activity
11/06/2003US20030207867 Method of treating a male or female animal in the treatment of a condition where inhibition of a cGMP-specific PDE is of a therapeutic benefit comprising treating said animal with an effective amount of a pharmaceutical composition with carriers
11/06/2003US20030207846 Treatment of pain, inflammation, and inflammation-related disorders with a combination of a cyclooxygenase-2 selective inhibitor and aspirin
11/06/2003US20030207823 Novel diabetes imaging probes
11/06/2003US20030207796 Specifically bind a carbohydrate target wherein sialic acid is linked at the nonreducing terminus of a glycoside to a galactose or galactosamine residue through an alpha 2-6 linkage are able to inhibit the conversion of human Factor X
11/06/2003US20030207446 Infectious papillomavirus pseudoviral particles
11/06/2003US20030207435 Have increased anti-coagulation activity and resistance to inactivation by serpins
11/06/2003US20030207263 Method of screening therapeutic agents
11/06/2003US20030206983 Administering a fruit extract obtained from a fruit of the plant family Solanaceae, such as tomato
11/06/2003US20030206960 Delivery of microparticle-conjugated drugs for inhibition of stenosis
11/06/2003US20030206889 Methods of treating anemia using recombinant adeno-associated virus virions
11/06/2003CA2487245A1 An injection made from ixeris sonchifolia hance for treatment of cardio-cerebral vascular diseases and fundus diseases and method of producing thereof
11/06/2003CA2483314A1 Piperidinyl-and piperazinyl-sulfonylmethyl hydroxamic acids and their use as protease inhibitors
11/06/2003CA2483253A1 Use of compounds having ccr antagonism
11/06/2003CA2483155A1 Benzothiadiazepine derivatives, processes for their preparation and pharmaceutical compositions containing them
11/06/2003CA2483007A1 A dna enzyme to inhibit plasminogen activator inhibitor-1
11/06/2003CA2482996A1 Vitamin d3 upregulated protein 1 treats post-infarct myocardial ischemia
11/06/2003CA2480845A1 Adipocyte complement related protein zacrp8
11/06/2003CA2480497A1 Substituted pyrazine derivatives
11/06/2003CA2480291A1 Adipocyte complement related protein zacrp14
11/05/2003EP1359222A2 Hybrid human/porcine factor VIII
11/05/2003EP1358909A1 Heteroaryl-phenyl derivatives as factor xa inhibitors for use as antithrombotic and anticoagulant agents
11/05/2003EP1358887A1 Composition of traditional chinese medicines for preventing and treating cerebrovascular disease
11/05/2003EP1358332A2 A serpin in bifidobacteria
11/05/2003EP1358328A2 Regulation of human serotonin-like g protein-coupled recepter
11/05/2003EP1358325A2 Protein modification and maintenance molecules
11/05/2003EP1358323A2 Regulators of apoptosis
11/05/2003EP1358320A2 68730 and 69112 protein kinase molecules and uses therefor
11/05/2003EP1358215A2 Glycosaminoglycans derived from k5 polysaccharide having high antithrombin activity and process for their preparation
11/05/2003EP1358212A1 Methods for the synthesis of a modified hemoglobin solution
11/05/2003EP1358186A1 Laulimalide derivatives
11/05/2003EP1358178A2 Sulfonamide lactam inhibitors of factor xa
11/05/2003EP1358150A1 Use of bicyclic esters or amides for the treatment of diseases responsive to enhanced potassium channel activity
11/05/2003EP1357974A1 Novel compositions of potassium channel openers and protein kinase c inhibitors and use thereof
11/05/2003EP1357936A1 BIOCATALYTIC AND BIOMIMETIC GENERATION OF NITRIC OXIDE i IN SITU /i AT SUBSTRATE/BLOOD INTERFACES
11/05/2003EP1357929A2 Modulation of immune response and methods based thereon
11/05/2003EP1357925A2 Compositions containing an active fraction isolated from hedyotis diffusae and methods of use
11/05/2003EP1357909A1 Il-8 receptor antagonists
11/05/2003EP1212300B1 Azacycloalkanone serine protease inhibitors
11/05/2003EP1019047B1 Antithrombotic agents
11/05/2003EP0796867B1 Peptide, bronchodilator and blood flow ameliorant
11/05/2003EP0713495B1 Methods of enhancing bioactivity of chemokines
11/05/2003EP0656366B1 Iron-lactoferrin combination and process for producing the same
11/05/2003EP0656061B1 Novel glycoforms of soluble complement receptor 1
11/05/2003EP0654078B1 A thrombin blood fraction for use in a medical procedure
11/05/2003CN1454257A Production of recombinant blood clotting factors in human cell lines
11/05/2003CN1454256A The high bone mass gene of 11q13.3
11/05/2003CN1454211A Nitrogen containing heterobicycles as factor xa inhibitors
11/05/2003CN1454204A IL-8 receptor antagonists
11/05/2003CN1454097A Polymer-modified synthetic proteins
11/05/2003CN1454095A A pharmaceutical composition for treating headache disease and process and uses thereof
11/05/2003CN1454086A High affinity small molecule C5A receptor modulators
11/05/2003CN1454084A Emulsion of perfluororganic compounds for medical purposes, method for producing said emulsion and methods for curing and preventing diseases with the aid of the emulsion
11/05/2003CN1453258A Active component in Herba Siegesbeckia orientalis with antithrombus effect and its prepn and application
11/05/2003CN1452991A Cerebral thrombus treating medicine
11/05/2003CN1452988A Hemopathy-treating chared medicine
11/05/2003CN1452972A Plant extractive composition containing ginkgetin and its use
11/05/2003CN1126758C Prepn. of blood coagulation factor IX compound
11/05/2003CN1126546C Reduction of infarction region using citicoline
11/04/2003US6642386 N-(4-carbamimidoyl-phenyl)-glycine derivatives
11/04/2003US6642277 And anthocyanin, cardiovascular disorders, inhibits oxidation of plasma LDL, stimulates TGF production and fibrinolysis and is an anticoagulant
11/04/2003US6642253 Thrombin inhibitors comprising an aminoisoquinoline group
11/04/2003US6642252 Anticoagulants in treating and preventing cardiovascular diseases, as anti-inflammatory agents, and as metastasis inhibitors in treating cancer.
11/04/2003US6642251 Antitumor, 2-indolinone derivatives
11/04/2003US6642242 Quinoline and quinazoline compounds useful in therapy
11/04/2003US6642227 Such as 2-methylsulfanyl-5-(2-phenylamino-pyrimidin-4-yl)-4-p-tolyl-thiophene-3 -carbonitrile; antiproliferative agents; stents
11/04/2003US6642224 Activated blood coagulation factor X inhibitors
11/04/2003US6642223 Benzoheterocyclic derivatives
11/04/2003US6642210 2-(N-pyrazolo)adenosines with application as adenosine A2A receptor agonists
11/04/2003US6642049 Human brain endothelial cells and growth medium and method for expansion of primitive CD34+CD38-bone marrow stem cells
11/04/2003US6642028 Isolated DNA encoding a Factor VIII protein; consensus splice sites which have been corrected relative to those of given nucleotide sequence
11/04/2003US6642008 Assays and therapies for latent viral infection
11/04/2003US6641807 Helper dependent adenoviral vectors encoding erythropoietin provide high levels of epo to achieve a long-term therapeutically effective dosage, and allow for repeat administration to patients with disorders such as anaemia of
11/04/2003US6641571 Reduction of postoperative complications of cardiopulmonary bypass (CPB) surgery
11/04/2003CA2094773C 2,4-dioxoimidazolidine derivatives
11/03/2003CA2427574A1 Plant bioreactor
10/2003
10/30/2003WO2003089569A2 Use of il-19, il-22 and il-24 to treat hematopoietic disorders
10/30/2003WO2003089439A1 Bicyclic heterocycles, medicaments containing these compounds, their use, and method for the production thereof
10/30/2003WO2003089434A2 IMIDAZO[1,2-a]PYRAZIN-8-YLAMINES METHOD OF MAKING AND METHOD OF USE THEREOF
10/30/2003WO2003089428A1 Tricyclic thrombin receptor antagonists
10/30/2003WO2003089426A1 Medicine for prevention and/or therapy of disseminated intravascular coagulation syndrome
10/30/2003WO2003088992A1 Novel screening method
10/30/2003WO2003088984A1 Compositions and methods for augmenting kidney function
10/30/2003WO2003088982A1 Device and method for treating restenosis with zinc
1 ... 376 377 378 379 380 381 382 383 384 385 386 387 388 389 390 391 392 393 394 395 396 ... 671